Pandha and colleagues reported that the downregulation of MHC-I molecules was observed in pancreatic cancer, whereas HLA-DRA in MHC-II molecules was upregulated [68]. The gene discussed is HLA-DRA; the disease is familial pancreatic carcinoma.